LDL and HDL Insights
A shift in understanding cholesterol reveals that while HDL is a marker of metabolic health, raising HDL through medication does not lower cardiovascular disease risk. Insights from Mendelian randomization studies highlight the complexity of heart disease, emphasizing that long-term exposure is crucial for understanding treatment outcomes. The evolving perspective on LDL challenges previous beliefs about its significance in health.In this clip
From this podcast
Huberman Lab
Dr Layne Norton: The Science of Eating for Health, Fat Loss & Lean Muscle | Huberman Lab Podcast #97
Related Questions
Explain Mendelian randomization studies related to LDL and heart disease
Explain Mendelian Randomization studies related to LDL and heart disease as discussed in the episode Dr Layne Norton: The Science of Eating for Health, Fat Loss & Lean Muscle | Huberman Lab Podcast #97 and the clip LDL and HDL Insights
Explain Mendelian Randomization studies related to LDL and heart disease as mentioned in the episode Dr Layne Norton: The Science of Eating for Health, Fat Loss & Lean Muscle | Huberman Lab Podcast #97 and the clip LDL and HDL Insights